Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer

NCT04638725 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT04638725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04638725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer
Lead sponsor
Centre Paul Strauss
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2021
Completion date
December 15, 2033
Enrollment
9,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer